Stock 300966 HUBEI GOTO BIOPHARM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hubei Goto Biopharm Co.,Ltd.

Equities

300966

CNE100004K94

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 22/05/2024 BST 		5-day change 1st Jan Change
20.02 CNY +1.88% Intraday chart for Hubei Goto Biopharm Co.,Ltd. -2.82% -12.84%
04-25 Hubei Goto Biopharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-09 Certain A Shares of Hubei Goto Biopharm Co.,Ltd. are subject to a Lock-Up Agreement Ending on 9-APR-2024. CI

Business Summary

Hubei Goto Biopharm Co Ltd is a China-based company mainly engaged in the research and development, production and sales of steroidal drug raw materials. The Company's main products are starting materials and intermediates required for the production of steroid drugs. The starting materials refer to the products obtained from the conversion of plant sterols through biological fermentation technology. These products are important raw materials for downstream pharmaceutical intermediates and active pharmaceutical ingredient manufacturers and belong to the upstream products in the steroid drug industry chain. The Company's intermediate products mainly include sex hormone intermediates, progesterone intermediates, corticosteroid intermediates and other products.

Number of employees: 631

Sales per Business

CNY in Million2022Weight2023Weight Delta
Self-produced
69.7 %
442 73.1 % 395 69.7 % -10.62%
Not Self-produced
30.3 %
163 26.9 % 172 30.3 % +5.37%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
77.2 %
507 83.8 % 438 77.2 % -13.65%
Overseas
22.8 %
98 16.2 % 129 22.8 % +31.62%

Managers

Managers TitleAgeSince
Zu Bin Xi CEO
 Chief Executive Officer 53 14/05/06
Xiang Dong Liu DFI
 Director of Finance/CFO 50 30/09/16
Ming Lei Li BRD
 Director/Board Member 46 31/07/08
Wen Jing Chen SEC
 Corporate Secretary 50 31/12/08

Members of the board

Members of the board TitleAgeSince
Cheng Cai Xia BRD
 Director/Board Member 74 15/10/18
Jian Yang BRD
 Director/Board Member 54 15/10/18
Zu Bin Xi CEO
 Chief Executive Officer 53 14/05/06
Ming Lei Li BRD
 Director/Board Member 46 31/07/08
Xiang Dong Liu DFI
 Director of Finance/CFO 50 30/09/16
Jian Sheng Ji BRD
 Director/Board Member 53 15/10/18
Jian Jun Jiang CHM
 Chairman 59 30/04/06
Wei Ren BRD
 Director/Board Member 38 30/04/12
Qing Fu Zhang BRD
 Director/Board Member 57 15/08/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 115,278,902 44,700,440 ( 38.78 %) 0 38.78 %

Shareholders

NameEquities%Valuation
Bosera Asset Management Co., Ltd.
0.1088 %
64,300 0.1088 % 157 786 ¥
Broad Fund Management Co. Ltd.
0.0711 %
42,000 0.0711 % 103 064 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.000968 %
572 0.000968 % 1 404 ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.000968 %
572 0.000968 % 1 404 ¥
Penghua Fund Management Co., Ltd.
0.000968 %
572 0.000968 % 1 404 ¥
GF Fund Management Co., Ltd.
0.000630 %
372 0.000630 % 913 ¥
Manulife TEDA Fund Management Co., Ltd.
0.000484 %
286 0.000484 % 702 ¥
Lion Fund Management Co., Ltd.
0.000484 %
286 0.000484 % 702 ¥
CICC Fund Management Ltd.
0.000484 %
286 0.000484 % 702 ¥
Truvalue Asset Management Co. Ltd.
0.000484 %
286 0.000484 % 702 ¥

Company contact information

Hubei Goto Biopharm Co., Ltd.

33/F, Bldg 1, Global Financial City Jiangshan South Road, Wolong Avenue

441057, Xiangyang

+

http://www.gotopharm.com
address Hubei Goto Biopharm Co.,Ltd.(300966)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
HUBEI GOTO BIOPHARM CO.,LTD. Stock Hubei Goto Biopharm Co.,Ltd.
-12.84% 313M
CSL LIMITED Stock CSL Limited
-2.24% 89.22B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 40.49B
BIOGEN INC. Stock Biogen Inc.
-15.73% 32.79B
UCB Stock UCB
+64.13% 26.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-21.28% 14.52B
INCYTE CORPORATION Stock Incyte Corporation
-8.50% 13.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.07% 11.6B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-13.06% 11.5B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.94% 8.82B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300966 Stock
  4. Company Hubei Goto Biopharm Co.,Ltd.